12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

• Hanger HNGR stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
• Biophytis BPTS stock rose 13.92% to $0.99. The company's market cap stands at $16.2 million.
• IsoPlexis ISO shares rose 12.31% to $3.74. The company's market cap stands at $146.1 million.
• Delcath Systems DCTH shares increased by 11.13% to $4.89. The company's market cap stands at $38.6 million.
• Plus Therapeutics PSTV shares moved upwards by 10.0% to $0.55. The company's market cap stands at $12.2 million. The company's, Q2 earnings came out today.
• Vallon Pharmaceuticals VLON stock increased by 9.6% to $0.55. The market value of their outstanding shares is at $5.8 million.

Losers

• Cellectar Biosciences CLRB stock decreased by 20.8% to $0.49 during Thursday's after-market session. Trading volume for this security closed at 125.5K, accounting for 91.1% of its average full-day volume over the last 100 days. The company's market cap stands at $30.1 million.
• Intuitive Surgical ISRG stock declined by 12.97% to $195.6. This security traded at a volume of 364.6K shares come close, making up 16.8% of its average volume over the last 100 days. The company's market cap stands at $70.2 billion. As per the press release, Q2 earnings came out today.
• Pluristem Therapeutics PSTI stock fell 7.41% to $1.0. The market value of their outstanding shares is at $32.3 million.
• ThermoGenesis Holdings THMO shares decreased by 6.69% to $0.22. At the close, ThermoGenesis Holdings's trading volume reached 50.5K shares. This is 2.7% of its average volume over the last 100 days. The company's market cap stands at $6.8 million.
• Idera Pharmaceuticals IDRA stock declined by 5.88% to $0.39. The market value of their outstanding shares is at $20.6 million.
• Purple Biotech PPBT stock fell 5.63% to $2.35. The market value of their outstanding shares is at $42.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.